Transactions of Managers and Closely Associated Persons
Attached are copies of two filings with the Luxembourg Commission de Surveillance…
Alvotech further strengthens liquidity by securing term loan facility of $75 million
July 01, 2026 04:00 ET | Source: Alvotech — $75 million additional…
Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio
REYKJAVIK, Iceland, June 8, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global…
